Year-End Termination

HPS GROUP, LLC for RARE DISEASE THERAPEUTICS

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

To provide wiavers of product and facility user fees for small companies developing orphan drugs, as considered by HR 2900 and S 1082

LobbyistCovered position, as disclosed
STEVEN GROSSMAN N/A

Contacted: UNDETERMINED; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 2900 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.